The Osaka-based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first hal...
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biolog...
South Korea based Genexine has announced that it is the first domestic pharmaceutical company to have been approved for ...
Ten COVID-19 vaccine candidates are currently in clinical trials (as of 4 June). These are listed in the below, in appro...
Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...
Daiichi Sankyo Company, Limited has announced its decision to develop a genetic (mRNA) vaccine for the novel corona viru...
Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently workin...
In collaboration with the International Pharmaceutical Students’ Federation’s (IPSF) and the International F...
China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...
Gernam firm BioNTech SE closed USD112.55 million debt financing agreement to support the development of the company&rsqu...
Moderna, Inc. announced on 11 June 2020 about progress on the late-stage development of mRNA-1273, the Company&rsqu...
Heat degradation of the proteins in vaccines render these expensive and precious biomedical products ineffective. Scient...
A recent Phase I clinical trial performed at the University Medical Center Hamburg-Eppendorf for a Middle East respirato...
UK-based AstraZeneca and the University of Oxford partnered on the global development and distribution ...
Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...
US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have announced that...
The Coalition for Epidemic Preparedness Innovations (CEPI) on 3 June 2020 announced a new partnering agreement to advanc...
